WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2015113494) BIFUNCTIONAL FUSION PROTEIN, PREPARATION METHOD THEREFOR, AND USE THEREOF
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2015/113494    International Application No.:    PCT/CN2015/071718
Publication Date: 06.08.2015 International Filing Date: 28.01.2015
IPC:
C07K 19/00 (2006.01), C07K 16/24 (2006.01), C07K 14/705 (2006.01), C12N 15/62 (2006.01), C12N 15/63 (2006.01), C12N 5/10 (2006.01), A61K 38/17 (2006.01), A61K 39/395 (2006.01), A61P 37/02 (2006.01)
Applicants: BEIJING HANMI PHARMACEUTICAL CO., LTD. [CN/CN]; No. 10 Tianzhu West Road Tianzhu Airport Industrial Zone A, Shunyi District. Beijing 101312 (CN)
Inventors: CHEN, Guoqiang; (CN).
LIU, Jiawang; (CN).
SONG, Nanmeng; (CN).
YANG, Yaping; (CN).
CHA, Mi Young; (CN)
Agent: BEIJING INTELLEGAL INTELLECTUAL PROPERTY AGENT LTD.; 1802, 1803, 1805 Tower B, Grand Place No 5 Huizhong Road, Chaoyang District Beijing 100101 (CN)
Priority Data:
201410042808.6 28.01.2014 CN
Title (EN) BIFUNCTIONAL FUSION PROTEIN, PREPARATION METHOD THEREFOR, AND USE THEREOF
(FR) PROTÉINE DE FUSION BIFONCTIONNELLE, PROCÉDÉ DE PRÉPARATION S'Y RAPPORTANT ET SON UTILISATION
(ZH) 双功能融合蛋白及其制备方法和用途
Abstract: front page image
(EN)The present invention provides a bifunctional fusion protein comprising the extracellular region of CTLA4 and an anti-IL-17 antibody, a gene encoding the protein, a vector comprising the gene, a host cell comprising the vector, and a pharmaceutical composition containing the protein.
(FR)La présente invention concerne une protéine de fusion bifonctionnelle comprenant la région extracellulaire de CTLA4 et un anticorps anti-IL -17, un gène codant pour la protéine, un vecteur comprenant ce gène, une cellule hôte comprenant le vecteur, et une composition pharmaceutique contenant la protéine.
(ZH)本发明提供了包含CTLA4胞外区和抗IL-17抗体的双功能融合蛋白、编码该蛋白的基因、含有该基因的载体、含有该载体的宿主细胞以及含有该蛋白的药物组合物。
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: Chinese (ZH)
Filing Language: Chinese (ZH)